Abo-Dya NE - Search Results

1

Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review.

Kumi RO, Oti B, Abo-Dya NE, Alahmdi MI, Soliman MES. Kumi RO, et al. Molecules. 2022 Nov 16;27(22):7915. doi: 10.3390/molecules27227915. Molecules. 2022. PMID: 36432016 Free PMC article. Review.

2

Pharmacophore-based Identification of Potential Mutant Isocitrate Dehydrogenases I/2 Inhibitors: An Explorative Avenue in Cancer Drug Design.

Poonan P, Peters XQ, Soliman MES, Alahmdi MI, Abo-Dya NE. Poonan P, et al. Anticancer Agents Med Chem. 2023;23(8):953-966. doi: 10.2174/1871520623666221129163001. Anticancer Agents Med Chem. 2023. PMID: 36453510

3

Probing into the Flap-dimer Dynamics of the Mycobacterium tuberculosis Kasa Enzyme Binding Landscape Provides the Underlying Inhibitory Mechanisms of JSF-3285 and 5G.

Adewumi AT, Oluyemi WM, Adewumi N, Adekunle YA, Alahmdi MI, Abo-Dya NE, Soliman MES. Adewumi AT, et al. Curr Top Med Chem. 2023;23(12):1065-1080. doi: 10.2174/1568026623666230125124433. Curr Top Med Chem. 2023. PMID: 36698229

4

Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated BTK^Cys481 Waldenström Macroglobulinemia: A Computational Approach.

Elamin G, Aljoundi A, Alahmdi MI, Abo-Dya NE, Soliman MES. Elamin G, et al. Among authors: abo dya ne. Anticancer Agents Med Chem. 2024;24(11):813-825. doi: 10.2174/1871520623666230208102609. Anticancer Agents Med Chem. 2024. PMID: 36752293

5

The Unusual Architecture of RNA-Dependent RNA Polymerase (RdRp)'s Catalytic Chamber Provides a Potential Strategy for Combination Therapy against COVID-19.

Metwally K, Abo-Dya NE, Alahmdi MI, Albalawi MZ, Yahya G, Aljoundi A, Salifu EY, Elamin G, Ibrahim MAA, Sayed Y, Fanucchi S, Soliman MES. Metwally K, et al. Among authors: abo dya ne. Molecules. 2023 Mar 20;28(6):2806. doi: 10.3390/molecules28062806. Molecules. 2023. PMID: 36985777 Free PMC article.

6

Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds.

Issahaku AR, Mncube SM, Agoni C, Kwofie SK, Alahmdi MI, Abo-Dya NE, Sidhom PA, Tawfeek AM, Ibrahim MAA, Mukelabai N, Soremekun O, Soliman MES. Issahaku AR, et al. Among authors: abo dya ne. J Mol Model. 2023 Mar 30;29(4):122. doi: 10.1007/s00894-023-05516-5. J Mol Model. 2023. PMID: 36995499

7

Exploring the Effects of Chirality of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl) phenyl]imidazolidine-2,4-dione and its Derivatives on the Oncological Target Tankyrase 2. Atomistic Insights.

Quintina Peters X, Poonan P, Salifu Yakubu E, Issa Alahmdi M, Abo-Dya NE, Soliman M. Quintina Peters X, et al. Among authors: abo dya ne. Curr Pharm Biotechnol. 2023 Mar 30. doi: 10.2174/1389201024666230330084017. Online ahead of print. Curr Pharm Biotechnol. 2023. PMID: 37005548

8

A novel small molecule inhibitor of p38⍺ MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation.

Abouleisa RRE, Miller JM, Gebreil A, Salama ABM, Dwenger M, Abdelhafez H, Wahid RM, Adewumi AT, Soliman MES, Abo-Dya NE, Mohamed TMA. Abouleisa RRE, et al. Among authors: abo dya ne. Br J Pharmacol. 2023 Dec;180(24):3271-3289. doi: 10.1111/bph.16209. Epub 2023 Aug 30. Br J Pharmacol. 2023. PMID: 37547998 Free PMC article.

9

Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a Novel 2-phenylquinazolinone Derivative in Cancer Therapy- An In-silico Investigation Therapy.

Peters XQ, Elamin G, Aljoundi A, Alahmdi MI, Abo-Dya NE, Sidhom PA, Tawfeek AM, Ibrahim MAA, Soremekun O, Soliman MES. Peters XQ, et al. Among authors: abo dya ne. Curr Pharm Biotechnol. 2024;25(10):1288-1303. doi: 10.2174/1389201024666230815145001. Curr Pharm Biotechnol. 2024. PMID: 37581526

10

Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp).

Metwally K, Abo-Dya NE, Hamdan AME, Alrashidi MN, Alturki MS, Aly OM, Aljoundi A, Ibrahim M, Soliman MES. Metwally K, et al. Among authors: abo dya ne. Cell Biochem Biophys. 2023 Dec;81(4):697-706. doi: 10.1007/s12013-023-01163-y. Epub 2023 Sep 2. Cell Biochem Biophys. 2023. PMID: 37658974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters